Histogen Inc. (HSTO) Financials

HSTO Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2023 5.8 million 1.4 million
June 30, 2023 13.5 million 5.3 million
March 31, 2023 16.1 million 5.7 million
Dec. 31, 2022 19.1 million 5.7 million

HSTO Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -2.7 million -7000
June 30, 2023 -2.4 million 32000
March 31, 2023 -2.6 million 419000
Dec. 31, 2022 -2.4 million 89000

HSTO Net Income

No data available :(

HSTO Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 4.9 million - -
June 30, 2023 7.3 million 4.2 million 4.5 million
March 31, 2023 9.7 million 4.3 million 4.6 million
Dec. 31, 2022 12.1 million 4.4 million 4.6 million

HSTO Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 4.3 million
June 30, 2023 4.3 million
March 31, 2023 4.3 million
Dec. 31, 2022 3.2 million

HSTO Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 - 660000 2.9 million -
June 30, 2023 - 536000 1.6 million -
March 31, 2023 - 993000 2.5 million -
Dec. 31, 2022 1000 1.1 million 1.9 million -

HSTO Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 5000 62000
June 30, 2023 5000 38000
March 31, 2023 5000 38000
Dec. 31, 2022 4000 38000

HSTO Revenue by Segment

Graph available only for paid members. Upgrade to see it.

HSTO

Price: $0.02

52 week price:
0.02
0.55

Payout Ratio Range:
-14.40%
-0.74%

Earnings Per Share: -2.81 USD

P/E Ratio: -0.12

Exchange: OEM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 31330

Market Capitalization: 897069

Links: